| Mcknight Place Extended Care | |
| Two Mcknight Place, Saint Louis, Missouri 63124 | |
| (314) 993-2221 | |
| Name | Mcknight Place Extended Care |
|---|---|
| Location | Two Mcknight Place, Saint Louis, Missouri |
| Certified By | Medicare |
| No. of Certified Beds | 70 |
| Occupancy Rate | 92.29% |
| Medicare ID (CCN) | 265849 |
| Legal Business Name | Mcknight Place Extended Care Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1003933607 |
| Organization Name | MCKNIGHT PLACE EXTENDED CARE LLC |
| Doing Business As | MCKNIGHT PLACE EXTENDED CARE |
| Address | 2 Mcknight Pl, Saint Louis, MO 63124 |
| Phone Number | 314-993-2221 |
News Archive
New research published in this month's Rheumatology journal has found that having gout doubles the risk of heart attack and stroke. The research tracked the health of more than 205,000 gout patients using data spanning five decades to determine links between gout and heart attack and stroke.
Malaria control strategies must keep up with the rapidly changing patterns of malaria infection in low transmission settings, according to the authors of a new Review, published in The Lancet. Whereas women and young children suffer from the greatest burden of malaria in high transmission areas, an increasing proportion of malaria cases in low transmission settings are occurring in adult men, sometimes concentrated in small geographic areas and sharing certain occupations or behaviours.
The brains of people with type 1 diabetes show signs of accelerated aging that correlate with slower information processing, according to research led by the University of Pittsburgh Graduate School of Public Health.
State spending on transitional housing supports for youth "aging out" of foster care can make a big difference in preventing homelessness, incarceration, substance abuse and early childbirth, according to a new study by social work researchers at Case Western Reserve University.
Genzyme, a Sanofi company, announced today the European Medicines Agency (EMA) has accepted the filing of the marketing authorization application (MAA) for once-daily oral teriflunomide for the treatment of relapsing forms of multiple sclerosis (MS).
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
New research published in this month's Rheumatology journal has found that having gout doubles the risk of heart attack and stroke. The research tracked the health of more than 205,000 gout patients using data spanning five decades to determine links between gout and heart attack and stroke.
Malaria control strategies must keep up with the rapidly changing patterns of malaria infection in low transmission settings, according to the authors of a new Review, published in The Lancet. Whereas women and young children suffer from the greatest burden of malaria in high transmission areas, an increasing proportion of malaria cases in low transmission settings are occurring in adult men, sometimes concentrated in small geographic areas and sharing certain occupations or behaviours.
The brains of people with type 1 diabetes show signs of accelerated aging that correlate with slower information processing, according to research led by the University of Pittsburgh Graduate School of Public Health.
State spending on transitional housing supports for youth "aging out" of foster care can make a big difference in preventing homelessness, incarceration, substance abuse and early childbirth, according to a new study by social work researchers at Case Western Reserve University.
Genzyme, a Sanofi company, announced today the European Medicines Agency (EMA) has accepted the filing of the marketing authorization application (MAA) for once-daily oral teriflunomide for the treatment of relapsing forms of multiple sclerosis (MS).
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $650 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 31.21 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 1.12 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 43.42 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.87 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 13.04 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.11 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 92.75 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 17.99 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 52.82 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 7.94 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 41.03 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 25.95 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 13.33 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.51 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 50.14 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 65.75 | 82.93 |
News Archive
New research published in this month's Rheumatology journal has found that having gout doubles the risk of heart attack and stroke. The research tracked the health of more than 205,000 gout patients using data spanning five decades to determine links between gout and heart attack and stroke.
Malaria control strategies must keep up with the rapidly changing patterns of malaria infection in low transmission settings, according to the authors of a new Review, published in The Lancet. Whereas women and young children suffer from the greatest burden of malaria in high transmission areas, an increasing proportion of malaria cases in low transmission settings are occurring in adult men, sometimes concentrated in small geographic areas and sharing certain occupations or behaviours.
The brains of people with type 1 diabetes show signs of accelerated aging that correlate with slower information processing, according to research led by the University of Pittsburgh Graduate School of Public Health.
State spending on transitional housing supports for youth "aging out" of foster care can make a big difference in preventing homelessness, incarceration, substance abuse and early childbirth, according to a new study by social work researchers at Case Western Reserve University.
Genzyme, a Sanofi company, announced today the European Medicines Agency (EMA) has accepted the filing of the marketing authorization application (MAA) for once-daily oral teriflunomide for the treatment of relapsing forms of multiple sclerosis (MS).
› Verified 5 days ago
Friendship Village Sunset Hills Location: 12651 Village Circle Drive, Saint Louis, Missouri 63127 Phone: (314) 270-7777 | |
Christian Extended Care & Rehabilitation Location: 11160 Village North Drive, Saint Louis, Missouri 63136 Phone: (314) 355-8010 | |
Delmar Gardens South Location: 5300 Butler Hill Road, Saint Louis, Missouri 63128 Phone: (314) 842-0588 | |
Chestnut Rehab And Nursing Location: 10954 Kennerly Road, Saint Louis, Missouri 63128 Phone: (314) 843-4242 | |
Royal Oak Nursing & Rehab Location: 4960 Laclede Avenue, Saint Louis, Missouri 63108 Phone: (314) 361-6240 |